Programme
MIBio 2022 Programme
08:00 Registration opens
09:00 Opening remarks
09:15 Pharmaceutical Development of Biologics, Past Present and Future
Paul Varley | VP CMC Development, Alchemab Therapeutics Ltd.
09:45 Challenges of Low Dosing and Stability
Jordan Bye | Senior Scientist, Immunocore
10:15 Morning Coffee, Exhibition and Posters
11:00 Building a New Biology: Design and Construction of Synthetic Cells
Yuval Elani – Asst. Professor & UKRI Future Leaders Fellow, Imperial College
11:30 Process Development for First in Human biopharmaceuticals: the role of change control in manufacturing
Luca Badiali | Associate Director, Kymab Ltd, a Sanofi Company
12:00 Lunch Break, Exhibition and Posters
13:15 Introduction to the afternoon session
13:30 Lipid nanoparticles to accelerate development and patient access to cell therapies
Sara Pereira | Senior Scientist, AstraZeneca
14:00 Discussion Panel
15:00 Exhibitors highlights
15:30 Coffee break, Exhibition and Posters
16:00 Materials and production considerations for LNPs
Söhnke Voss | Business Development Manager, EMEA, Avanti Polar Lipids
16:30 Cell and Gene Therapy Product Development and Associated Challenges
Farnaz Esmaeili | Project Manager, Regulatory Affairs, Cell and Genetherapy, GSK
17:00 Concluding remarks
17:10 Conference ends